Antion is at the forefront of cell and gene therapy innovation, with a groundbreaking platform that enables simultaneous gene expression and silencing. It's multiplex engineering technology is highly efficient, reducing safety risks and improving the likelihood of effective therapeutic outcomes.
Cooperation possibilities
Antion is a leader in microRNA (miRNA) engineering. We offer attractive out-licensing opportunities, co-development services, and actively seek strategic partnerships to fully leverage the unique capabilities of our technology platform.
- https://antionbio.com/
- +41 22 552 03 96
- info@antionbio.com
- Marco Alessandrini